| CARVIEW |
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases & Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS
- Real World & Healthcare Data
- Health Data Apps & AI
- Analytics Research Accelerator
- Expert Ecosystem
- AI Patient & HCP Profiling- Commercial
- AI Patient & Provider Profiling- Med Affairs
- AI Patient & HCP Profiling- Healthcare
- Natural Language Processing
- Market Access Insights
- Direct-to-Patient Research
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI®
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESCommitment to Global Health
Accelerating global health
We help people live longer, healthier lives by advancing clinical research, delivering healthcare insights, and improving decisions through data, prioritizing impact in regions with limited access to high quality care.
Tackling global health challenges
Health systems strengthening
Health security, pandemic preparedness and AMR
Health access
IQVIA drives better health outcomes through research and emerging technologies. As a trusted life sciences partner we:
- Share insights via the IQVIA Institute for Human Data Science
- Advance genomics for personalized treatments
- Leverage AI to boost research and operational efficiency
- Lead in global healthcare thought leadership
IQVIA Global Health
Our vision for global health
Our vision is to advance healthcare everywhere by transforming data and local insights into scalable and sustainable solutions, delivered with trusted partners globally and in low‑ and middle‑income countries.
Making an impact through collaboration
IQVIA is working with The Global Fund and (RED) to strengthen healthcare in low- and middle-income countries, especially in Africa. Projects like the Data Science Catalytic Fund, launched with Rwanda, aim to drive innovation and speed up disease outbreak response. Through collaboration and technology, IQVIA is helping tackle global health challenges.
Use cases in global health
Pandemic preparedness
IQVIA is working with Europe’s Health Emergency Preparedness and Response Authority (HERA), harnessing data to better identify and respond to future health threats.
The role of data in pandemic preparedness.
Avoiding potential health emergencies requires development, production and distribution of medical countermeasures (MCM), including medicines, vaccines, diagnostic tests, and masks. HERA also has a coordination role, working with European Member States and agencies including the European Centre for Disease Prevention and Control and the European Medicines Agency. Together they gather data on health threats, European stocks of MCM and relevant response capabilities.
The Advanced Technology for Health Intelligence and Action IT system (Athina) is critical in bringing together intelligence on Europe’s pandemic preparedness. IQVIA helped define the appropriate real-world datasets to track MCM supply chains. We are also enabling the tracking of MCM shortages and identification of potential vulnerabilities and strategic dependencies, giving HERA the insight it needs to strengthen Europe’s future response.
Mpox: accelerating vaccine development in a growing health crisis
Since 2022, there has been a steady increase in mpox cases and deaths in the Democratic Republic of the Congo (DRC), which in 2024 spread to multiple countries and developed into a full-scale healthcare emergency. Vaccinations are a powerful tool to prevent infection and control disease spread. As part of efforts to develop a new mpox vaccine, we partnered with a major pharmaceutical company to rapidly launch effectiveness trials during the outbreak. Using our GRAM (Geographic Risk Assessment and Mitigation) approach, we identified trial sites in Kinshasa and Goma, DRC, accelerating vaccine development.
Using data and insight to address AMR
Improve surveillance to address a global threat.
In September 2024, the UN General Assembly convened leaders from politics, healthcare, and life sciences to set new goals and actions to address antimicrobial resistance (AMR).
The University of Liverpool’s Civic Health Innovation Labs, funded by the UK Office for Life Sciences, is developing an antimicrobial learning system using IQVIA’s Health Analytics Network to improve antibiotic prescribing practices and reduce resistance. IQVIA also built a customizable forecast model to estimate demand for injectable antibiotics, validated in eight countries and adaptable for use in low- and middle-income regions.
Marburg: enhancing the world’s readiness to rapidly implement life-saving clinical research for vaccines
The role of strategic partnerships to act fast.
In conjunction with national and regional collaborators, IQVIA and the Coalition for Epidemic Preparedness Innovations (CEPI) are working to enhance the world’s preparedness to rapidly conduct life-saving clinical research for vaccines and other biological countermeasures against emerging infectious diseases.
Furthermore, in the following nine days after the first patient, the coalition of partners supported the enrollment of an additional 700 subjects in the trial. This speed was facilitated by the years of investment we have made establishing relationships, local talent and technical capabilities in Africa and due to strategic partnerships already in place with CEPI and the Government of Rwanda.
Thought Leadership
Building on Africa’s sickle cell disease clinical trials: An avenue to create greater capacity for research in noncommunicable diseases
Navigating the complex landscape of sickle cell disease
Actions to increase awareness and scale up sustainable access solutions
Using more and better data to solve the puzzle of antimicrobial resistance
Rethinking the tuberculosis response in times of change: The current state of affairs and perspectives on the future
The malaria response in perspective
Navigating global health shifts and overcoming challenges through innovation
Improving access to affordable and sustainable oncological care in Africa
Identifying unmet need and high-impact actions to address it
Navigating Antimicrobial Resistance
Challenges and Future Opportunities for the Antimicrobial Products Subscription Model